General Information of the Compound
| Compound ID |
CP0905110
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-((2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyrazin-3-yl)methyl)morpholine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H21ClN4O
|
||||||||||||||||||
| Molecular Weight |
368.868
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(-c2nc3cnc(C4CC4)cn3c2CN2CCOCC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H21ClN4O/c21-16-5-3-15(4-6-16)20-18(13-24-7-9-26-10-8-24)25-12-17(14-1-2-14)22-11-19(25)23-20/h3-6,11-12,14H,1-2,7-10,13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
ACBPNASACKZFEB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04657, Solute carrier family 2, facilitated glucose transporter member 1
Protein ID: PT06319, Solute carrier family 2, facilitated glucose transporter member 2
Protein ID: PT06387, Solute carrier family 2, facilitated glucose transporter member 3
Protein ID: PT03440, Solute carrier family 2, facilitated glucose transporter member 4